ARTICLE | Financial News
Synta planning follow-on
January 6, 2012 2:21 AM UTC
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) proposed late Thursday to sell shares in a follow-on underwritten by Jefferies; Canaccord; and Roth Capital Partners. Details were not disclosed. Synta's gane...